• Key responsibilities include leading primary market research, conducting data analytics, mapping competitive landscape through various sources, driving actionable insights from qualitative and quantitative data, producing executive-level presentations, and overseeing internal junior teams and external vendors• Executed 10+ global product strategy projects across multiple specialty areas (oncology, neurology, rare diseases), with primary focus on product planning and commercial assessment. Example projects include:• Conducted commercial due diligence for two late-stage vaccine assets with $8B projected peak sales through primary and secondary market research to inform go/no-go investment • Drove strategic product planning for 3 vaccine pipelines with >$1B peak sale potential through sizing eligible population, mapping competitive landscape, conducting financial modeling and evaluating development feasibility, to inform portfolio prioritization• Performed KOL interviews to assess opportunities for a potential best-in-class gene-editing asset for sickle cell disease• Consolidated insights from primary market research (payer interview) and secondary sources (vendor database, company news, earnings calls) to inform contracting and access strategies for 3 gene therapies against rare diseases • Performed primary market research and developed market access strategies for a first-in-class oral analgesic by profiling and synthesizing perceptions of 50+ key stakeholders (payers, health systems, distributors, retail pharmacy stores) and policy implications (e.g., 340B program)• Led quantitative analysis of 200+ physician surveys to identify market demand and inform commercial planning for a late-stage breast cancer (now FDA-approved); received internal Putnam Appreciates Award for exceptional quant/data analysis

- Invented novel drug formulations that led to 5 publications (4 first/co-first author) and 1 US patent (pending)- Generated proof-of-concept experimental results that helped the lab secure $~2M grants - Delivered 5 presentations in domestic/international conferences and won 2 poster awards

The mission of UNC-CH Microbiome Club is to build a comprehensive network and create learning opportunities for local microbiome researchers including graduate students and postdoc. Please follow us on Twitter (@unc_microbiome)! (The credit of the club logo design goes to our club member, Marissa Bivins!)

- Took business courses including Technology Commercialization, Business Fundamentals, Financial Accounting, Communication, Leadership, Project Management.

- Designed a novel transdermal patch prototype and initiated the business plan for product development with 2 cross-disciplinary teammates- Identified market potential through online research and 4 in-person interviews with physicians

- Developed oral delivery systems for microbe and biologic therapeutics- Supported in-house manufacturing of feasibility batch

- Working with 4 cross-disciplinary team members to provide consultation on regulatory landscape of AAV therapies for Enzerna Biosciences.- Applied literature/database search, teamwork, communication and project management skills and delivered a mid-project presentation to Enzerna Biosciences.

- Tried expression of N-terminal cysteine-functionalized interleukin-2 in E. coli and Pichia Pastoris- Characterized protein expression with LC-MS, SDS-PAGE and Western Blotting

- Conducted market research to judge novelty and market potential of an anti-malarial drug candidate- Drafted assessment report

- Fabricated stem cell-encapsulated hydrogel with photo-induced reaction- Characterized cell behavior in a variety of physical and biochemical cues with immuno-staining and RT-PCR

- Learned cancer drug use in clinical settings

- Got trained on ELISA, Western Blotting and cell culturing